Sunitinib

DYC Heng, C Kollmannsberger - Small Molecules in Oncology, 2009 - Springer
Sunitinib is an oral multikinase inhibitor that blocks the vascular endothelial growth factor
receptor (VEGFR), platelet-derived growth factor receptor (PDGFR) alpha and beta, c-kit …

Sunitinib.

DY Heng, C Kollmannsberger - … Dans les Recherches sur le Cancer, 2010 - europepmc.org
Sunitinib is an oral multikinase inhibitor that blocks the vascular endothelial growth factor
receptor (VEGFR), platelet-derived growth factor receptor (PDGFR) alpha and beta, c-kit …

Sunitinib

DYC Heng, C Kollmannsberger - Recent results in …, 2010 - pubmed.ncbi.nlm.nih.gov
Sunitinib is an oral multikinase inhibitor that blocks the vascular endothelial growth factor
receptor (VEGFR), platelet-derived growth factor receptor (PDGFR) alpha and beta, c-kit …

Sunitinib

DYC Heng, C Kollmannsberger - Small Molecules in Oncology - infona.pl
Sunitinib is an oral multikinase inhibitor that blocks the vascular endothelial growth factor
receptor (VEGFR), platelet-derived growth factor receptor (PDGFR) alpha and beta, c-kit …

[引用][C] Sunitinib

DYC HENG, C KOLLMANNSBERGER - Recent results in cancer research, 2010 - Springer

[引用][C] Sunitinib

DYC Heng, C Kollmannsberger - Small Molecules in Oncology, 2010 - Springer